The 20th World Congress of the International Society for Diseases of the Esophagus (ISDE) was successfully held in Edinburgh, UK, from September 22nd to 24th. The conference focused on the epidemiology, molecular mechanisms, diagnostics, and novel therapies of esophageal diseases. A nine-member team from West China Hospital's Thoracic Surgery Department, led by Professor Chen Longqi, attended the prestigious event.

At the congress, the team presented on various topics including clinical research, basic research, translational research, and new clinical technologies in esophageal cancer, showcasing our hospital's innovative and forward-looking research achievements in the field, which sparked widespread interest and discussion among attending experts. Additionally, eight of our research findings were displayed as posters during the conference.

Professor Chen Longqi also chaired the ISDE China Special Session - CSDE Symposium, themed "Clinical Trials for Esophageal Squamous Cell Carcinoma in East Asia: Perspectives and Lessons Learned from Principal Investigators." The session featured in-depth sharing and discussion on the latest treatment advances and original clinical trial results for esophageal cancer in East Asia, becoming a highlight of the congress and garnering significant attention from scholars worldwide.

Since its establishment in 1979, the International Society for Diseases of the Esophagus (ISDE) has been dedicated to fostering scientific and medical knowledge exchange in the field of esophageal diseases and encouraging basic and clinical research. Our Thoracic Surgery Department has been actively involved in ISDE activities since its inception, sharing and exchanging our cutting-edge research findings and surgical techniques with international peers, thereby enhancing the hospital's global influence. Looking ahead, we will continue to strengthen international exchanges and cooperation, striving for new breakthroughs and innovations in the perioperative treatment of esophageal cancer, basic medical science, translational medicine, technological innovation, and multicenter clinical research.